Viiv Healthcare sales and marketing update

ViiV announced the launch of Triumeq dolutegravir/ abacavir/lamivudine in Japan to treat HIV infection. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) will be responsible for distribution and...